Vantage Hemp Co. Announces Commercial Launch of CBG Isolate and Significant Regulatory Developments

U.S. producer expands its pharmaceutical-grade product portfolio and shares progress with Brazilian Health Regulatory Agency Greeley, Colorado, Nov. 12, 2024 (GLOBE NEWSWIRE) — Vantage Hemp Co. (“Vantage” or “the Company”), a globally accredited cannabinoid extractor and manufacturer, announces the commercial launch of its pharmaceutical-grade CBG (cannabigerol) isolate. This new product offering, launching globally in November 2024, is […]